Sophia Umansky defends use of weight loss drug Mounjaro amid backlash on social media

Sophia Umansky says she’ll continue using Mounjaro despite criticism, calling out haters and affirming her autonomy.


Pop Culture & Art May 11, 2025
Photo: Kyle Richards

Sophia Umansky, daughter of reality TV stars Kyle Richards and Mauricio Umansky, has addressed backlash over her decision to use the weight loss drug Mounjaro. 

The 25-year-old spoke to People magazine, making it clear that she stands by her choice despite criticism from social media users.

“Everyone needs to calm down and live their own lives,” she said, responding to accusations that she is promoting unhealthy body standards. Umansky had previously revealed in a late April TikTok video that she was using Mounjaro, a medication approved for Type 2 diabetes, to assist with weight management. She also noted experiencing hair loss as a side effect.

@sophiakylieee

taking hair loss remedy recommendations 🙃

♬ original sound - Sophia Umansky

Critics quickly reacted online, with some claiming she was already thin and accusing her of setting a bad example. Umansky dismissed the negative comments, asserting, “I’m an adult, I can do what I want.” She emphasized that her decision was made in consultation with a medical professional and shared that her mother, Real Housewives of Beverly Hills star Kyle Richards, has been supportive.

The young television personality clarified that her motivation was not about disliking her appearance but about boosting self-confidence. “I just think it’ll help me feel a little bit more confident, a little bit cuter,” she said.

Sophia joins a growing list of celebrities who have publicly acknowledged using weight loss drugs, including Amy Schumer, Tracy Morgan, and Kelly Clarkson. As the conversation around these medications continues, Umansky’s response highlights a personal stance on health, body image, and autonomy.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ